Glazer Jacob, Huskamp Haiden A, McGuire Thomas G
Tel Aviv University and Boston University.
Forum Health Econ Policy. 2012 Mar 30;15(2). doi: 10.1515/1558-9544.1296.
Existing economic approaches to the design and evaluation of health insurance do not readily apply to coverage decisions in the multi-tiered drug formularies characterizing drug coverage in private health insurance and Medicare. This paper proposes a method for evaluating a change in the value of a formulary to covered members based on the economic theory of price indexes. A formulary is cast as a set of demand-side prices, and our measure approximates the compensation (positive or negative) that would need to be paid to consumers to accept the new set of prices. The measure also incorporates any effect of the formulary change on plan drug acquisition costs and "offset effects" on non-drug services covered by the plan. Data needed to calculate formulary value are known or can be forecast by a health plan. We illustrate the method with data from a move from a two- to a three-tier formulary.
现有的医疗保险设计与评估经济方法并不容易应用于私人医疗保险和医疗保险中药物覆盖的多层级药品目录的覆盖决策。本文基于价格指数的经济理论,提出了一种评估药品目录对参保成员价值变化的方法。药品目录被视为一组需求侧价格,我们的衡量方法近似于为使消费者接受新价格集而需支付给他们的补偿(正或负)。该衡量方法还纳入了药品目录变化对计划药品采购成本的任何影响以及对计划所涵盖的非药品服务的“抵消效应”。计算药品目录价值所需的数据是健康计划已知的或可预测的。我们用从两层级药品目录转变为三层级药品目录的数据说明了该方法。